CN1650861A - Medicinal solution for treating ulceration and inflammation - Google Patents
Medicinal solution for treating ulceration and inflammation Download PDFInfo
- Publication number
- CN1650861A CN1650861A CN 200410064571 CN200410064571A CN1650861A CN 1650861 A CN1650861 A CN 1650861A CN 200410064571 CN200410064571 CN 200410064571 CN 200410064571 A CN200410064571 A CN 200410064571A CN 1650861 A CN1650861 A CN 1650861A
- Authority
- CN
- China
- Prior art keywords
- inflammation
- present
- medicinal solution
- solution
- metronidazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
An exterior-applied medicine 'Kuianling' in the form of solution for treating dermatopathy and oral ulcer contains proportionally zinc gluconate, cont (fossyol), VB, desicaine and sodium benzoate.
Description
Technical field
The present invention relates to a kind of external used medicine that is used for the treatment of dermatosis and oral ulcer.
Technical background
The oral ulcer and the various dermatosis chronic disease that have intractable, recurrent at present, all kinds of skin infection sexually transmitted disease (STD)s changes have a strong impact on people's physical and mental health as skin pruritus, eczema, urticaria, dermatitis, acne and decubital ulcer etc., people take multiple medicine and medical procedure treatment, but effect is all not very good.
Summary of the invention
Technical problem to be solved by this invention provides a kind of have good and clinical curative effect and nontoxic, side effect and the treatment dermatosis of drug dependence and the external used medicine solution of oral ulcer.
The present invention adopts following technical scheme: contain following composition by weight in the 10000ml drug solution of the present invention:
Zinc gluconate 150-200g metronidazole (metronidazole) 20-30g
Vitamin B6 1-2g tetracaine 5-10g sodium benzoate 10-15g
The preparation method of solution of the present invention is for adopting following composition by weight:
Zinc gluconate 150-200g metronidazole (metronidazole) 20-30g
Vitamin B6 1-2g tetracaine 5-10g sodium benzoate 10-15g
Above-mentioned component is processed into adds water after powder mixes and make 10000ml solution, precipitate after-filtration, sterilization, packing in 24 hours and promptly make.
The present invention is Main Ingredients and Appearance with the zinc gluconate, and pharmacodynamic experiment proves that organic zinc absorbs ideal can bring into play curative effect fast, experiment confirm zinc deficiency oral mucosa hypertrophy parakeratosis, and zinc deficiency blocks taste pore, and the oxygeusia degree is reduced; Zinc deficiency has reduced the vigor of hydroxyl PEPA A, and digestive function is obviously descended.Zinc has the reparation of acceleration, promotes the normal skin cutin to generate, and powerful convergence is arranged, and effect antipruritic, analgesia is arranged, and can promote the healing and the rehabilitation of pathological changes such as skin ulcer, wound, eczema, and the skin drag of enhancing and autoimmune powerful effect are arranged.
Be higher than oral once amount through experiment confirm and clinical observation zinc gluconate, the aqueous solution external safety of one times of content does not have any toxicity, side effect.The zinc gluconate powder that the present invention adopts is that state-run regular pharmaceutical factory produces, the sufficient price lower (about 1000 yuan of every Kg) in medicine source.And this raw material medicine all meets the medicine inspection acceptable quality level.Manufacturing condition of the present invention requires clear and definite, and technological process is simple, and system is joined technical operation and easily grasped, but medicament compartment equal ordinary production in general pharmaceutical factory does not need the sharp equipment of special height.
Drug solution antiinflammatory infection of the present invention, restoration and protection skin mucosa, restrain, relieve the pain, antipruritic short repair in trauma healing.Drug solution of the present invention is applicable to intractable, recurrent oral ulceration, and produce effects speed, anti-recurrence, to various dermatosis chronic diseases all have curative effect preferably as skin itching disease, eczema, neurodermatitis, acne and wound etc.Drug solution of the present invention contain cough, affected part is embrocated, soak all can.The present invention is an aqua, and every bottle of 100ml seals, puts shady and cool place and preserves, and storage life is 2 years.Because drug solution of the present invention (prove effective fast, late result is high, relapse rate is low) evident in efficacy therapeutic domain is wider, is higher than other like products and nontoxic, side effect through clinical verification curative effect for many years.Colorless and odorless easy to use does not stain medicated clothing.And medicine source abundance, with low cost, preparation does not simply need high investment, can obtain remarkable society and economic benefit.Event is clinical and market prospect is very optimistic.
The clinical observation on the therapeutic effect table:
Subordinate list 1 is treatment recurrent, intractable oral cavity ulcer.
Systematic observation 70 examples, wherein the child accounts for 78%, and all with symptoms such as the different malnutrition of degree, immunologic hypofunction, monophagia, anorexia, different foods.Healing person's 59 examples (accounting for 84.3%) after the week after medication, produce effects 11 example points 15.7%, total effective rate reaches 100%.
Table 1:
Subordinate list 2 is to several dermatosis observation of curative effect
Observe 153 routine skin cases altogether, wherein have acne, skin pruritus, eczema, decubital ulcer evident in efficacy.Curative effect sees Table 2:
Vitiligo, psoriasis then curative effect are not good enough.
Table 2:
| The example number | Take a turn for the better (routine %) | Cure (routine %) | Invalid (routine %) | Total effective rate | |
| Acne | 26 | ?3 | ?22 | ?1 | ?96％ |
| Skin itching | 32 | ?4 | ?28 | ?0 | ?100％ |
| Eczema | 18 | ?4 | ?14 | ?0 | ?100％ |
| Neural dermatitis | 16 | ?0 | ?16 | ?0 | ?100％ |
| The spirit measles | 14 | ?3 | ?10 | ?1 | ?93％ |
| Decubital ulcer | 24 | ?0 | ?24 | ?0 | ?100％ |
| Psoriasis | 9 | ?5 | ?0 | ?4 | ?55％ |
| Vitiligo | 14 | ?3 | ?0 | ?11 | ?21.4％ |
| Amount to | 153 | ?22(14.4％) | ?114(74.5％) | ?17(11.1％) | ?88.8％ |
The specific embodiment
The embodiment of the invention is as shown in table 3, contains following composition by weight in the 10000ml drug solution of the present invention:
Table 3:
| Composition | Content (weight g) | ||
| Zinc gluconate | ????150 | ????175 | ????200 |
| Metronidazole (metronidazole) | ????25 | ????30 | ????20 |
| Vitamin B6 | ????1 | ????1.5 | ????2 |
| Tetracaine | ????7.5 | ????5 | ????10 |
| Sodium benzoate | ????10 | ????12.5 | ????15 |
Claims (1)
1, a kind of medicinal solution for treating ulceration and inflammation is characterized in that containing in the 10000ml drug solution following composition by weight:
Zinc gluconate 150-200g metronidazole (metronidazole) 20-30g
Vitamin B6 1-2g tetracaine 5-10g sodium benzoate 10-15g
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410064571 CN1270710C (en) | 2004-11-30 | 2004-11-30 | Medicinal solution for treating ulceration and inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410064571 CN1270710C (en) | 2004-11-30 | 2004-11-30 | Medicinal solution for treating ulceration and inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1650861A true CN1650861A (en) | 2005-08-10 |
| CN1270710C CN1270710C (en) | 2006-08-23 |
Family
ID=34868852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410064571 Expired - Fee Related CN1270710C (en) | 2004-11-30 | 2004-11-30 | Medicinal solution for treating ulceration and inflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1270710C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007055912A (en) * | 2005-08-23 | 2007-03-08 | Kowa Co | Medicinal composition for treating stomatitis |
| FR2899475A1 (en) * | 2006-04-10 | 2007-10-12 | Galderma Res & Dev | Composition, useful to prepare a drug to treat and/or the prevent rosacea, preferably vascular disorders caused by rosacea, comprises metronidazole and zinc, in a medium |
| CN105748516A (en) * | 2016-03-30 | 2016-07-13 | 黄宇松 | Pharmaceutical composition for treating repeated oral ulcers |
-
2004
- 2004-11-30 CN CN 200410064571 patent/CN1270710C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007055912A (en) * | 2005-08-23 | 2007-03-08 | Kowa Co | Medicinal composition for treating stomatitis |
| FR2899475A1 (en) * | 2006-04-10 | 2007-10-12 | Galderma Res & Dev | Composition, useful to prepare a drug to treat and/or the prevent rosacea, preferably vascular disorders caused by rosacea, comprises metronidazole and zinc, in a medium |
| CN105748516A (en) * | 2016-03-30 | 2016-07-13 | 黄宇松 | Pharmaceutical composition for treating repeated oral ulcers |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1270710C (en) | 2006-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2937101A1 (en) | Semi-fluidic composition for lubricating, moisture retaining, disinfecting, sterilizing and method using the same | |
| CN103285028A (en) | Composite antibacterial agent of chitosan and organosilicone quaternary ammonium salt and preparation method of composite antibacterial agent | |
| JP2013507328A (en) | Compositions containing benzoic acid as an active component in combination with an organic acid preservative, and uses thereof | |
| CN110946874A (en) | Hyaluronic acid composition for relieving osteoarthritis | |
| CN101843637B (en) | External spray for preventing and treating beriberi and preparation method | |
| CN1270710C (en) | Medicinal solution for treating ulceration and inflammation | |
| CN109464341B (en) | Health care composition | |
| Sareen et al. | Wheat grass-a wonder herb | |
| CN103800401B (en) | Granulation promoting healing ointment | |
| CN102755255A (en) | Nanoscale liposome external preparation for relieving itching | |
| CN108452211A (en) | A kind of compound chitosan renovation agent | |
| US20110070159A1 (en) | Compositions comprising red microalgae polysaccharides and metals | |
| CN103655593A (en) | Composite medicine preparation for prevention and treatment of bacterium and virus polyinfection diseases of livestock as well as preparation method and application thereof | |
| CN108066401A (en) | A kind of drug for being used to treat rhinitis | |
| CN104941010B (en) | A kind of Medical vagina lubricating fluid and preparation method thereof | |
| CN105107014A (en) | Medical biological anti-allergy dressing for skins and method for preparing medical biological anti-allergy dressing | |
| CN105055713A (en) | Drug composition for preventing or curing bedsore and preparation method thereof | |
| CN1879650A (en) | Medicinal powder for treating beriberi and preparation method thereof | |
| CN1182852C (en) | Medicine for curing dermatosis | |
| CN1082372C (en) | Liquid medicine for treatment of bromidrosis, and its preparing method | |
| CN112826923A (en) | Composition for treating oral ulcer, oral ulcer membrane and preparation method thereof | |
| RU2753638C2 (en) | Gel composition for skin treatment | |
| RU2367425C1 (en) | Cream for milking ''dennica'' | |
| RU2486912C1 (en) | Agent for vaginal douche in first stage of treatment of vaginal thrush (vaginal yeast) | |
| US20060177516A1 (en) | Food-supplement composition suitable for promoting iron absorption |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060823 Termination date: 20091230 |